Terms: = Gastric cancer AND LIFR, SJS2, 3977, ENSG00000113594, SWS, STWS, CD118 AND Treatment
4 results:
1. The leukemia inhibitory factor regulates fibroblast growth factor receptor 4 transcription in gastric cancer.
Di Giorgio C; Bellini R; Lupia A; Massa C; Urbani G; Bordoni M; Marchianò S; Rosselli R; De Gregorio R; Rapacciuolo P; Sepe V; Morretta E; Monti MC; Moraca F; Cari L; Ullah KRS; Natalizi N; Graziosi L; Distrutti E; Biagioli M; Catalanotti B; Donini A; Zampella A; Fiorucci S
Cell Oncol (Dordr); 2024 Apr; 47(2):695-710. PubMed ID: 37945798
[TBL] [Abstract] [Full Text] [Related]
2. Identification and validation of ferroptosis-related biomarkers and the related pathogenesis in precancerous lesions of gastric cancer.
Kuang Y; Yang K; Meng L; Mao Y; Xu F; Liu H
Sci Rep; 2023 Sep; 13(1):16074. PubMed ID: 37752199
[TBL] [Abstract] [Full Text] [Related]
3. Lidocaine Suppresses gastric cancer Development Through Circ_ANO5/miR-21-5p/lifr Axis.
Guan E; Liu H; Xu N
Dig Dis Sci; 2022 Jun; 67(6):2244-2256. PubMed ID: 34050852
[TBL] [Abstract] [Full Text] [Related]
4. Sequencing topotecan and etoposide plus cisplatin to overcome topoisomerase I and II resistance: a pharmacodynamically based Phase I trial.
Aisner J; Musanti R; Beers S; Smith S; Locsin S; Rubin EH
Clin Cancer Res; 2003 Jul; 9(7):2504-9. PubMed ID: 12855624
[TBL] [Abstract] [Full Text] [Related]